LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 14.58 | 84.90 | 67 | 663 | 0.1010 | -0.0767 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 14.58 | 84.90 | 521 | 663 | 0.7853 | 0.8435 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 16.29 | 84.90 | 34 | 766 | 0.0443 | -0.2504 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 16.29 | 84.90 | 1005 | 766 | 1.3105 | 1.1778 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 16.29 | 84.90 | 76 | 766 | 0.0991 | -0.0343 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 16.29 | 84.90 | 609 | 766 | 0.7942 | 0.8600 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.99 | 84.90 | 64 | 898 | 0.0712 | -0.0796 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.99 | 84.90 | 1008 | 898 | 1.1213 | 1.0684 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.99 | 84.90 | 102 | 898 | 0.1135 | 0.0554 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 17.99 | 84.90 | 545 | 898 | 0.6063 | 0.7266 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 19.69 | 84.90 | 240 | 1239 | 0.1936 | 0.3082 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 19.69 | 84.90 | 1002 | 1239 | 0.8084 | 0.8930 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 19.69 | 84.90 | 112 | 1239 | 0.0904 | 0.0743 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 19.69 | 84.90 | 510 | 1239 | 0.4115 | 0.5897 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.40 | 84.90 | 351 | 1454 | 0.2413 | 0.4138 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.40 | 84.90 | 977 | 1454 | 0.6716 | 0.8149 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.40 | 84.90 | 134 | 1454 | 0.0921 | 0.1178 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 21.40 | 84.90 | 603 | 1454 | 0.4145 | 0.6133 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.10 | 84.90 | 454 | 1616 | 0.2809 | 0.4836 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.10 | 84.90 | 1038 | 1616 | 0.6422 | 0.8022 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.10 | 84.90 | 150 | 1616 | 0.0928 | 0.1433 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 23.10 | 84.90 | 570 | 1616 | 0.3527 | 0.5651 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.81 | 84.90 | 555 | 1769 | 0.3137 | 0.5350 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.81 | 84.90 | 966 | 1769 | 0.5459 | 0.7419 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.81 | 84.90 | 161 | 1769 | 0.0910 | 0.1573 | MN20160318_Q02 | M17 |